- ISIN
- US45783C1018
- CUSIP
- 45783C101
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Mar 19, 2021
Highlights
- Market Cap
- $55.00M
- Enterprise Value
- $49.98M
- EPS (TTM)
- -$7.04
- Gross Profit (TTM)
- -$12.00K
- EBITDA (TTM)
- -$45.96M
- Year Range
- $5.67 - $42.79
- Target Price
- $7.00
- ROA (TTM)
- -23.64%
- ROE (TTM)
- -42.80%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TIL Performance Chart
Instil Bio, Inc. (TIL) is down 26.3% since the beginning of the year. At $8 per share, TIL is trading 81.0% below its 52-week high of $43. Investors who bought $1,000 worth of TIL shares 5 years ago would now be looking at an investment worth $26.
Loading charts...
Returns By Period
Instil Bio, Inc. (TIL) has returned -26.27% so far this year and -72.65% over the past 12 months.
Instil Bio, Inc.
- 1D
- 0.00%
- 1M
- 2.66%
- YTD
- -26.27%
- 6M
- -24.77%
- 1Y
- -72.65%
- 3Y*
- -11.36%
- 5Y*
- -51.77%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
TIL Monthly Returns History
Based on dividend-adjusted daily data since Mar 19, 2021, TIL's average daily return is -0.10%, while the average monthly return is +0.42%. At this rate, an investment would double in approximately 13.8 years.
Historically, 33% of months were positive and 67% were negative. The best month was Sep 2024 with a return of +382.6%, while the worst month was Nov 2022 at -59.7%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 10 months.
On a daily basis, TIL closed higher 46% of trading days. The best single day was Sep 13, 2024 with a return of +81.9%, while the worst single day was Jan 6, 2026 at -45.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -35.82% | 26.06% | -7.42% | -3.16% | 1.13% | 0.50% | -26.27% | ||||||
| 2025 | 16.61% | -9.70% | -13.63% | -25.98% | 109.73% | -22.71% | 15.22% | 12.50% | -33.85% | -1.23% | -27.66% | -13.79% | -42.38% |
| 2024 | 54.86% | 1.02% | -9.40% | 0.19% | -1.20% | -3.74% | 18.37% | 14.53% | 382.58% | -52.81% | -15.30% | -29.06% | 150.52% |
| 2023 | 29.19% | -4.52% | -14.97% | -1.10% | -8.20% | -8.15% | -0.91% | -17.38% | -5.12% | -13.32% | -8.68% | 12.46% | -39.52% |
| 2022 | -32.14% | -7.58% | 0.19% | -34.23% | -15.06% | -23.06% | 22.08% | -7.80% | -6.92% | -31.82% | -59.70% | -52.63% | -96.32% |
| 2021 | -5.14% | -18.14% | -13.30% | 8.54% | -22.10% | 25.25% | -5.17% | 13.96% | 7.90% | -22.16% | -35.29% |
Benchmark Metrics
Instil Bio, Inc. has an annualized alpha of -39.99%, beta of 1.74, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since March 22, 2021.
- This stock participated in 238.02% of S&P 500 Index downside but only -4.34% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -39.99%
- Beta
- 1.74
- R²
- 0.07
- Upside Capture
- -4.34%
- Downside Capture
- 238.02%
Return for Risk
Risk / Return Rank
TIL ranks 10 for risk / return — in the bottom 10% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Instil Bio, Inc. (TIL) and compare them to S&P 500 Index.
| TIL | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.77 | 2.39 | -3.16 |
Sortino ratioReturn per unit of downside risk | -1.04 | 3.25 | -4.30 |
Omega ratioGain probability vs. loss probability | 0.85 | 1.43 | -0.58 |
Calmar ratioReturn relative to maximum drawdown | -0.88 | 3.11 | -4.00 |
Martin ratioReturn relative to average drawdown | -1.18 | 14.38 | -15.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Instil Bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Instil Bio, Inc. was 98.83%, occurring on Dec 7, 2023. The portfolio has not yet recovered.
The current Instil Bio, Inc. drawdown is 98.50%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -98.83%Dec 2023 | 2y 8mo | — | 5y 2moMar 2021 - now |
2021 pullback2021 | -9.59%Mar 2021 | 2d | 1d | 3dMar 2021 - Mar 2021 |
Drawdown Indicators
| TIL | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.83% | -56.78% | -42.05% |
Max Drawdown (1Y)Largest decline over 1 year | -82.27% | -9.10% | -73.17% |
Max Drawdown (3Y)Largest decline over 3 years | -92.12% | -18.90% | -73.22% |
Max Drawdown (5Y)Largest decline over 5 years | -98.64% | -25.43% | -73.21% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -98.50% | 0.00% | -98.50% |
Average DrawdownAverage peak-to-trough decline | -82.55% | -10.72% | -71.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.79% | 1.97% | +59.82% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Instil Bio, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Instil Bio, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TIL in comparison with other companies in the Biotechnology industry. Currently, TIL has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TIL
Add Instil Bio, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TIL